Vertex kidney drug povetacicept succeeds in trial for IgAN
A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston. Brian Snyder | Reuters…
Biotech is resistant to AI disruption. Josh Brown likes these two stocks in the industry
(This is The Best Stocks in the Market , brought to you by Josh Brown and Sean Russo…
These 4 charts show the scale of Novo Nordisk’s woes
Novo Nordisk was the first company to make a GLP-1 drug for weight loss and became Europe’s most…
Gilead to acquire cancer therapy developer Arcellx
A Gilead Sciences office is shown in Foster City, California, U.S. May 1, 2018. Stephen Lam | Reuters…
The Fed has cut rates with the S&P 500 at a record four times before. Here’s what happened next
It’s not often that the Federal Reserve eases monetary policy with the stock market this strong. But when…
What’s likely to move the market in the next trading session
Stocks @ Night is a daily newsletter delivered after hours, giving you a first look at tomorrow and…